Authors:
JACQUY C
DELEPAUT B
VANDAELE S
VAERMAN JL
ZENENBERGH A
BRICHARD B
VERMYLEN C
CORNU G
MARTIAT P
Citation: C. Jacquy et al., A PROSPECTIVE-STUDY OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - MRD LEVEL AT THE END OF INDUCTION IS A STRONG PREDICTIVE FACTOR OF RELAPSE, British Journal of Haematology, 98(1), 1997, pp. 140-146
Authors:
VAERMAN JL
MOUREAU P
DELDIME F
LEWALLE P
LAMMINEUR C
MORSCHHAUSER F
MARTIAT P
Citation: Jl. Vaerman et al., ANTISENSE OLIGODEOXYRIBONUCLEOTIDES SUPPRESS HEMATOLOGIC CELL-GROWTH THROUGH STEPWISE RELEASE OF DEOXYRIBONUCLEOTIDES, Blood, 90(1), 1997, pp. 331-339
Authors:
HEUSTERSPREUTE M
DERCLAYE I
GALA JL
VANGEET C
FERRANT A
MALCHAIRE Y
THONNARD J
VAERMAN JL
PHILIPPE M
Citation: M. Heusterspreute et al., BETA-THALASSEMIA IN INDIGENOUS BELGIAN FAMILIES - IDENTIFICATION OF ANOVEL MUTATION, Human genetics, 98(1), 1996, pp. 77-79
Authors:
JACQUY C
DELEPAUT B
VANDAELE S
VAERMAN JL
ZEENEBERGH A
BRICHARD V
VERMYLEN C
CORNU G
MARTIAT P
Citation: C. Jacquy et al., PROSPECTIVE FOLLOW-UP OF MRD IN CHILDHOOD B-CELL ALL TREATED ACCORDING TO THE FRALLE-93 PROTOCOL IN A SINGLE INSTITUTION, Blood, 88(10), 1996, pp. 1903-1903
Citation: Jl. Vaerman et P. Martiat, HOW DO ANTISENSE OLIGODEOXYNUCLEOTIDES INHIBIT THE GROWTH OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS - RESPONSE, Blood, 87(9), 1996, pp. 4020-4020
Authors:
PHILIPPE M
HEUSTERSPREUTE M
DERCLAYE I
GALA JL
VANGEET C
FERRANT A
MALCHAIRE Y
THONNARD J
VAERMAN JL
Citation: M. Philippe et al., BETA-THALASSEMIA IN THE INDIGENOUS BELGIAN FAMILIES - IDENTIFICATION OF A NOVEL MUTATION, Blood, 86(10), 1995, pp. 2600-2600
Citation: P. Martiat et al., NON-ANTISENSE INHIBITION OF HEMATOPOIETIC-CELL PROLIFERATION BY BCR ABL ANTISENSE OLIGODEOXYRIBONUCLEOTIDES/, Blood, 86(10), 1995, pp. 2681-2681
Authors:
VAERMAN JL
LAMMINEUR C
MOUREAU P
LEWALLE P
DELDIME F
BLUMENFELD M
Citation: Jl. Vaerman et al., BCR-ABL ANTISENSE OLIGODEOXYRIBONUCLEOTIDES SUPPRESS THE GROWTH OF LEUKEMIC AND NORMAL HEMATOPOIETIC-CELLS BY A SEQUENCE-SPECIFIC BUT NONANTISENSE MECHANISM, Blood, 86(10), 1995, pp. 3891-3896
Authors:
MARTIAT P
VANDAELE S
FERRANT A
STRAETMANS N
VANDENNESTE E
MAREVOET M
PHILIPPE M
VAERMAN JL
DEBRUYERE M
MICHAUX JL
Citation: P. Martiat et al., FREQUENT CONTAMINATION OF PBSC MOBILIZED USING CHEMOTHERAPY AND G-CSFIN INTERMEDIATE AND HIGH-GRADE LYMPHOMAS, EVEN WITHOUT BONE-MARROW INVOLVEMENT, Blood, 84(10), 1994, pp. 10000645-10000645
Authors:
NIZET Y
VANDAELE S
LEWALLE P
VAERMAN JL
PHILIPPE M
VERMYLEN C
CORNU G
FERRANT A
MICHAUX JL
MARTIAT P
Citation: Y. Nizet et al., LONG-TERM FOLLOW-UP OF RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS IN COMPLETE REMISSION USING CLONOGENEIC IGH PROBES AND THEPOLYMERASE CHAIN-REACTION, Blood, 82(5), 1993, pp. 1618-1625
Authors:
VAERMAN JL
LEWALLE P
VASSEUR M
BLUMENFELD M
MARTIAT P
Citation: Jl. Vaerman et al., EVALUATION OF THE CHIMERIC BCR-ABL GENE AS A TARGET FOR ANTISENSE INHIBITION BY OLIGONUCLEOTIDES, Blood, 82(10), 1993, pp. 10000119-10000119